ImmunityBio, Inc.IBRXNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank50
3Y CAGR-8.9%
5Y CAGR-17.6%
Year-over-Year Change
Return on equity
3Y CAGR
-8.9%/yr
Annual compound
5Y CAGR
-17.6%/yr
Recent acceleration
Percentile
P50
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 70.34% | -16.8% |
| 2024 | 84.56% | -14.9% |
| 2023 | 99.35% | +6.7% |
| 2022 | 93.12% | -35.0% |
| 2021 | 143.20% | -22.7% |
| 2020 | 185.17% | +439.7% |
| 2019 | -54.52% | +17.3% |
| 2018 | -65.91% | -49.6% |
| 2017 | -44.06% | -7.0% |
| 2016 | -41.17% | - |